• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性验证一种评估显著高胆红素血症风险的新策略。

Prospective validation of a novel strategy for assessing risk of significant hyperbilirubinemia.

机构信息

Division of General Pediatrics, Pediatrics Department, Hospital São João, Porto, Portugal.

出版信息

Pediatrics. 2011 Jan;127(1):e126-31. doi: 10.1542/peds.2009-2771. Epub 2010 Dec 13.

DOI:10.1542/peds.2009-2771
PMID:21149428
Abstract

OBJECTIVE

Our aim was to validate a strategy for assessing the risk of significant hyperbilirubinemia in newborns with gestational ages of ≥35 weeks by combining predischarge bilirubin percentile data with gestational age data, for a European, predominantly white population.

METHODS

We conducted a prospective cohort study with 463 newborns with gestational ages of ≥35 weeks who were admitted to the well-infant nursery. Total bilirubin levels were measured daily until discharge and once after discharge, between the third and eighth days of life, by using a Bilicheck device (Respironics, Murrysville, PA). The values obtained (<52 hours) were plotted on an hour-specific bilirubin nomogram to determine the infant's bilirubin percentile, expressed as a risk zone. Patients were assigned to 1 of 3 risk groups (very low, low, or high) on the basis of a combination of risk zone and gestational age data and were monitored prospectively for the development of significant hyperbilirubinemia. The 95% confidence interval (CI) for the prevalence of significant hyperbilirubinemia was estimated with the binomial distribution method.

RESULTS

Forty-four infants (11%) developed significant neonatal hyperbilirubinemia. The risks of developing significant hyperbilirubinemia were 1.3% (95% CI: 0.2%-3.7%) for the very low risk group (n = 230 [58.1%]), 3.4% (95% CI: 0.7%-9.8%) for the low risk group (n = 86 [21.7%]), and 47.50% (95% CI: 36.2%-59.0%) for the high risk group (n = 80 [20.20%]).

CONCLUSIONS

The proposed strategy, based on predischarge bilirubin level and gestational age data, was a valid method for significant hyperbilirubinemia risk assessment in our population.

摘要

目的

我们旨在通过结合早产儿胆红素百分位数据和胎龄数据,为欧洲主要是白人的人群验证一种评估胎龄≥35 周新生儿发生显著高胆红素血症风险的策略。

方法

我们进行了一项前瞻性队列研究,纳入了 463 名胎龄≥35 周的新生儿,这些新生儿被收入新生儿重症监护室。在住院期间,每天测量总胆红素水平,直至出院后第 3 至第 8 天,使用 Bilicheck 设备(Respironics,Murrysville,PA)测量一次。在特定时间的胆红素百分位图上绘制获得的胆红素值(<52 小时),以确定婴儿的胆红素百分位,并用风险区域表示。根据风险区域和胎龄数据的组合,将患者分为 3 个风险组(极低、低或高),并对其进行前瞻性监测,以确定是否发生显著高胆红素血症。使用二项式分布方法估计显著高胆红素血症的 95%置信区间(CI)。

结果

44 名婴儿(11%)发生了显著的新生儿高胆红素血症。极低风险组(n=230[58.1%])发生显著高胆红素血症的风险为 1.3%(95%CI:0.2%-3.7%),低风险组(n=86[21.7%])为 3.4%(95%CI:0.7%-9.8%),高风险组(n=80[20.2%])为 47.50%(95%CI:36.2%-59.0%)。

结论

基于出院前胆红素水平和胎龄数据的提出的策略是评估我们人群中显著高胆红素血症风险的有效方法。

相似文献

1
Prospective validation of a novel strategy for assessing risk of significant hyperbilirubinemia.前瞻性验证一种评估显著高胆红素血症风险的新策略。
Pediatrics. 2011 Jan;127(1):e126-31. doi: 10.1542/peds.2009-2771. Epub 2010 Dec 13.
2
A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.预测足月儿和近足月儿显著新生儿高胆红素血症的替代风险评估策略比较。
Pediatrics. 2008 Jan;121(1):e170-9. doi: 10.1542/peds.2006-3499.
3
Assessing jaundice in infants of 35-week gestation and greater.评估 35 周及以上胎龄婴儿的黄疸。
Curr Opin Pediatr. 2010 Jun;22(3):352-65. doi: 10.1097/MOP.0b013e328339603f.
4
Effect of predischarge bilirubin screening on subsequent hyperbilirubinemia.出院前胆红素筛查对后续高胆红素血症的影响。
Pediatrics. 2006 Oct;118(4):1796; author reply 1976-7. doi: 10.1542/peds.2006-1456.
5
Prediction of hyperbilirubinemia in near-term and term infants.近足月儿和足月儿高胆红素血症的预测
J Perinatol. 2001 Dec;21 Suppl 1:S63-72; discussion S83-7. doi: 10.1038/sj.jp.7210638.
6
[Validation of an hourly transcutaneous bilirubin nomogram in a population of term or late preterm newborn infants: preliminary results].[足月儿或晚期早产儿群体中每小时经皮胆红素列线图的验证:初步结果]
Minerva Pediatr. 2010 Jun;62(3 Suppl 1):113-5.
7
Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns.结合临床风险因素与血清胆红素水平预测新生儿高胆红素血症。
Arch Pediatr Adolesc Med. 2005 Feb;159(2):113-9. doi: 10.1001/archpedi.159.2.113.
8
Screening and early postnatal management strategies to prevent hazardous hyperbilirubinemia in newborns of 35 or more weeks of gestation.筛查和早期产后管理策略以预防 35 周及以上胎龄新生儿的危险高胆红素血症。
Semin Fetal Neonatal Med. 2010 Jun;15(3):129-35. doi: 10.1016/j.siny.2009.10.004. Epub 2010 Jan 19.
9
Transcutaneous bilirubinometer in assessment of neonatal jaundice in northern India.经皮胆红素仪在印度北部新生儿黄疸评估中的应用
Indian Pediatr. 2005 Jan;42(1):41-5.
10
Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia.用于预测新生儿显著高胆红素血症的经皮胆红素列线图。
Pediatrics. 2009 Oct;124(4):1052-9. doi: 10.1542/peds.2008-2322. Epub 2009 Sep 28.

引用本文的文献

1
Bilirubin nomograms for identification of neonatal hyperbilirubinemia in healthy term and late-preterm infants: a systematic review and meta-analysis.用于识别健康足月儿和晚期早产儿新生儿高胆红素血症的胆红素列线图:系统评价和荟萃分析
World J Pediatr. 2014 Aug;10(3):211-8. doi: 10.1007/s12519-014-0495-8. Epub 2014 Aug 15.
2
Applying data mining techniques to improve diagnosis in neonatal jaundice.应用数据挖掘技术提高新生儿黄疸的诊断水平。
BMC Med Inform Decis Mak. 2012 Dec 7;12:143. doi: 10.1186/1472-6947-12-143.
3
Development and validation of serum bilirubin nomogram to predict the absence of risk for severe hyperbilirubinaemia before discharge: a prospective, multicenter study.
建立并验证血清胆红素列线图预测出院时重度高胆红素血症风险缺失的价值:一项前瞻性、多中心研究。
Ital J Pediatr. 2012 Feb 1;38:6. doi: 10.1186/1824-7288-38-6.